The global ambition for AI-powered health tools often collides with the intricate realities of regulatory divergence. For product managers, digital health executives, and international regulatory…
·
·
8 min read
The field for diagnostic AI, once characterized by a patchwork of regulatory interpretations, has undergone a period of significant attempted realignment and subsequent legal challenge.…
·
·
8 min read
The FDA’s recent formalization of Predetermined Change Control Plans (PCCPs) marks a key moment for machine learning software in healthcare. This guidance fundamentally reshapes how…
·
·
8 min read
A single phrase in your software description can make the difference between a simple launch and a multi-year FDA clearance process. For digital health innovators,…
·
·
8 min read
Build compliant AI health solutions like Hello Heart. Understand FDA classification, data governance, and continuous validation for 2026 success.
·
·
9 min read
SaMD compliance is critical. Avoid 40% higher enforcement risk & market exclusion. Learn premarket strategy to cut clearance 30%.
·
·
6 min read
The global digital health field presents a paradox: immense opportunity for innovation alongside a labyrinth of regulatory frameworks. For AI health tools, particularly those functioning…
·
·
8 min read
The era of static, locked-down medical software clearances is rapidly drawing to a close. For digital health investors, product managers, and software engineers, understanding this…
·
·
8 min read
The regulatory field for artificial intelligence in healthcare is constantly evolving, and for developers of diagnostic imaging AI, clarity is paramount. The FDA has taken…
·
·
7 min read
The line between a helpful health application and a regulated medical device is often perceived as blurry, yet for digital health developers and product managers,…
·
·
8 min read